Bleakley Financial Group, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1936953
PARSIPPANY, NJ
Position in VRTX
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$7,692,098
+$622,403 QoQ
Shares Held
17,226
+10.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
13 quarters on record
Voting authority
Sole 0.011610356437942644.ToString("F0")%
Shared 0.ToString("F0")%
None 99.98838964356206.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bleakley Financial Group, LLC holds $16,625,065 across 16 Biotechnology names. VRTX ranks #1 (46.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
17,226 | $7,692,098 | |
| 2 | ANAB |
Anaptysbio, Inc
|
43,120 | $1,594,288 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
12,802 | $1,349,330 | |
| 4 | IBRX |
ImmunityBio, Inc.
|
163,572 | $1,254,597 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
14,316 | $1,074,988 | |
| 6 | BCAX |
Bicara Therapeutics Inc.
|
29,331 | $583,393 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,967 | $526,086 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
11,628 | $386,282 |
All Filings in VRTX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,692,098 | 17,226 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $7,069,695 | 15,594 | Shares | Sole | 2026-02-09 | |
| 2025-06-30 | $6,202,081 | 13,931 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $5,489,132 | 11,322 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $3,412,882 | 8,475 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $3,524,841 | 7,579 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $12,668,095 | 27,027 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $11,652,864 | 27,877 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $9,061,847 | 22,271 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $6,416,498 | 18,452 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,241,475 | 17,736 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,530,642 | 8,032 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,171,336 | 7,519 | Shares | Sole | 2023-02-07 | |
| No filing history on record for this holder in this stock. | ||||||